Head of Research & Development Salary at Sick Ag BETA

Director, Oncology TA Global Regulatory Affairs Strategy Lead Growing $1.5Bn+ Pharma Unique and positive culture RETAINED SEARCH Cornerstone Search Group has been retained again by a profitable $1.5Bn+ (and growing) pharma with a uniquely positive work environment that reflects its country’s renowned culture. With a product portfolio featuring a current oncology blockbuster that is still on the ascent and the upcoming launch of another anticipated oncology blockbuster, this company is in a very active phase of building out their clinical pipeline through both in-house research and in-licensing efforts. This hybrid role will lead US and Global regulatory activities in their Oncology therapeutic area, serve as the regulatory expert on cross-functional product development teams globally on their unpartnered assets, work with other pharmas on their partnered assets, and serve as the point of communications with the FDA on their product portfolio. You will have regular interaction with thei

Location: Mexico City or San Francisco (remote candidates considered) Company Overview Silica is a pioneering early-stage company leveraging enhanced rock weathering (ERW) to permanently remove CO₂ from the atmosphere, while improving soil health and increasing agricultural yields. We deploy innovative, scalable carbon removal techniques using silicate rock dust, working closely with farmers across Latin America, starting in Mexico. Silica was recently selected for Frontier’s ‘24 pre-purchases program, securing pre-purchases for carbon removal from Stripe, Shopify and Google. Position Overview The Head of Science will shape and drive the scientific and technical aspects of Silica’s ERW projects. You will oversee research and development, field trials, and the deployment of ERW strategies. This role requires a deep understanding of geochemistry, soil science, and carbon removal processes, as well as the ability to translate scientific insights into scalable, practical applications. This

DIRECTOR, GLOBAL REG AFFAIRS STRATEGY LEAD - ONCOLOGY Growing $1.5Bn+ revenue, $7Bn market cap, 550-person biotech 1 approved cancer blockbuster with 1 anticipated blockbuster in late Phase III Highly collaborative, no ego, transparent culture Strong female leadership representation including CEO and Head of R&D Globally lead multiple assets including 1st-in-class solid tumor candidates Cornerstone Search Group has been retained again by a profitable $1.5Bn+ (and growing) pharma with a uniquely positive work environment that reflects its country’s renowned culture. With a product portfolio featuring a current oncology blockbuster that is still on the ascent and the upcoming launch of another anticipated oncology blockbuster, this company is in a very active phase of building out their clinical pipeline through both in-house research and acquisition. This hybrid role will lead US and Global regulatory activities in their Oncology therapeutic area on a potential first-in-class asset, ser

DIRECTOR, GLOBAL REG AFFAIRS STRATEGY LEAD - ONCOLOGY Growing $1.5Bn+ revenue, $7Bn market cap, 550-person biotech 1 approved cancer blockbuster with 1 anticipated blockbuster in late Phase III Highly collaborative, no ego, transparent culture Strong female leadership representation including CEO and Head of R&D Globally lead first-in-class asset for solid tumors Cornerstone Search Group has been retained again by a profitable $1.5Bn+ (and growing) pharma with a uniquely positive work environment that reflects its country’s renowned culture. With a product portfolio featuring a current oncology blockbuster that is still on the ascent and the upcoming launch of another anticipated oncology blockbuster, this company is in a very active phase of building out their clinical pipeline through both in-house research and acquisition. This hybrid role will lead US and Global regulatory activities in their Oncology therapeutic area on a potential first-in-class asset, serve as the regulatory exp

DIRECTOR, GLOBAL REG AFFAIRS STRATEGY LEAD - ONCOLOGY Growing $1.5Bn+ revenue, $7Bn market cap, 550-person biotech 1 approved cancer blockbuster with 1 anticipated blockbuster in late Phase III Highly collaborative, no ego, transparent culture Strong female leadership representation including CEO and Head of R&D Globally lead multiple assets including first-in-class Cornerstone Search Group has been retained again by a profitable $1.5Bn+ (and growing) pharma with a uniquely positive work environment that reflects its country’s renowned culture. With a product portfolio featuring a current oncology blockbuster that is still on the ascent and the upcoming launch of another anticipated oncology blockbuster, this company is in a very active phase of building out their clinical pipeline through both in-house research and acquisition. This hybrid role will lead US and Global regulatory activities in their Oncology therapeutic area on a potential first-in-class asset, serve as the regulatory

Please Note: This position requires relocation to Copenhagen, Denmark. Candidates should only apply if they are able to move to this location. Relocation assistance will be provided. Head of R&D – Denmark About the Company Our client is an innovative clean-tech start-up on a mission to reduce global CO₂ emissions by transforming industrial waste gases into valuable, carbon-negative chemicals. Using advanced fermentation processes, they’re turning environmental challenges into sustainable solutions. With backing from major venture capital investors and a strategic growth trajectory, they’re poised for global impact and need a visionary Head of R&D to help lead the way. Role Overview The Head of R&D will be instrumental in driving the company’s bioprocess development, overseeing advanced strain engineering and bioprocess optimization. This leader will focus on innovation in strain development, as well as the refinement of existing products and processes. If you’re a skilled scientific le

Job Description Job Description Sweet Street is hiring full-time production workers for our food manufacturing plant on third shift. Candidates with at least 6 months of experience working in a fast-paced production line/manufacturing environment will be considered. We offer competitive wages and a full insurance benefit package after 90 days of service. 3rd shift hours: 9:30 pm to 6:00 am (Monday to Friday). Base pay $15/hr, plus $.50/hr shift premium, plus $1.50/hr add-on. All workers must meet the following criteria: Ability to fully communicate in English (read, write, speak, understand) Ability to stand throughout shift Ability to lift/carry 25-50 lbs. throughout shift Ability to learn quickly and adapt to changing instructions Ability to work in a fast-paced environment Reliable with a good attendance history *** NOTE: Use of tobacco products and e-cigarettes is not permitted on Sweet Street property. Due to food safety concerns, false nails, nail polish and false eyelashes are n

Job Description Job Description Cafe Sweet Street is looking for friendly, reliable, motivated, energetic, customer-oriented candidates who are available to work part time (up to 29 hrs/week) throughout the whole year. Quarterly and annual perfect attendance bonuses available to all employees. Flexible schedules available between 6:30 am and 5:00 pm, Monday to Friday. NO NIGHTS OR WEEKENDS! PURPOSE: To interface professionally with retail Café Sweet Street customers in a manner that creates a positive experience for all clientele and good public relations. RESPONSIBILITIES: Assist customers to the café to assure that all clientele have a positive experience. Maintain a professional demeanor and verbiage. Take and fulfill customer orders for food and beverage with an emphasis on efficient and professional customer service. Prepare and plate food items following preparation recipes or instructions, ingredient prep lists, proper portion control and sanitary food handling practices. Provid